Edward J Dulac III

EVP, Chief Financial Officer, Intellia Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Jul 22, 2026

Companies

Intellia Therapeutics, Inc.EVP, Chief Financial Officer −$0.2M

Trades

NTLA Sold 8,111 shares at $11.25 $0.1M Jul 22

NTLA Sold 4,677 shares at $18.00 · planned $0.1M Jul 2

NTLA Sold 6,379 shares at $9.21 $0.1M Jan 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.